3dyd
Human Tyrosine AminotransferaseHuman Tyrosine Aminotransferase
Structural highlights
Disease[ATTY_HUMAN] Defects in TAT are the cause of tyrosinemia type 2 (TYRO2) [MIM:276600]; also known as Richner-Hanhart syndrome. TYRO2 is an inborn error of metabolism characterized by elevations of tyrosine in the blood and urine, and oculocutaneous manifestations. Typical features include palmoplantar keratosis, painful corneal ulcers, and mental retardation.[1] Function[ATTY_HUMAN] Transaminase involved in tyrosine breakdown. Converts tyrosine to p-hydroxyphenylpyruvate. Can catalyze the reverse reaction, using glutamic acid, with 2-oxoglutarate as cosubstrate (in vitro). Has much lower affinity and transaminase activity towards phenylalanine.[2] [3] Evolutionary Conservation![]() Check, as determined by ConSurfDB. You may read the explanation of the method and the full data available from ConSurf. References
|
|
Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)
OCA- Human
- Tyrosine transaminase
- Andersson, J
- Arrowsmith, C H
- Berg, S Van Den
- Berglund, H
- Collins, R
- Dahlgren, L G
- Edwards, A M
- Flodin, S
- Flores, A
- Graslund, S
- Hammarstrom, M
- Johansson, A
- Johansson, I
- Karlberg, T
- Kotenyova, T
- Lehtio, L
- Moche, M
- Nilsson, M E
- Nordlund, P
- Nyman, T
- Olesen, K
- Persson, C
- Structural genomic
- Sagemark, J
- Schuler, H
- Thorsell, A G
- Tresaugues, L
- Weigelt, J
- Welin, M
- Wikstrom, M
- Wisniewska, M
- Aminotransferase
- Disease mutation
- Phenylalanine catabolism
- Plp
- Pyridoxal phosphate
- Sgc
- Transferase
- Tyrosine
- Tyrosine catabolism